Total planned funding: $404,393,416
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $63,932,268 |
| Malawi | $44,904,838 |
| Tanzania | $30,069,042 |
| South Africa | $29,090,903 |
| Zimbabwe | $28,391,509 |
| Kenya | $22,603,082 |
| Zambia | $21,751,569 |
| Lesotho | $18,444,579 |
| Asia Regional Program | $17,796,518 |
| Eswatini | $15,182,861 |
| Uganda | $14,792,470 |
| Nigeria | $14,406,387 |
| Botswana | $11,931,919 |
| Ethiopia | $11,315,679 |
| Namibia | $9,683,495 |
| Cameroon | $9,385,394 |
| Democratic Republic of the Congo | $9,341,181 |
| Western Hemisphere Region | $7,265,985 |
| South Sudan | $4,474,640 |
| Côte d'Ivoire | $4,285,167 |
| Haiti | $4,067,100 |
| Rwanda | $2,722,740 |
| Vietnam | $2,501,378 |
| Ukraine | $2,250,000 |
| Angola | $2,102,712 |
| Burundi | $1,700,000 |
Organizational Types
| University | $404,393,416 |
Program Areas
| Treatment | $136,029,521 |
| Prevention | $103,383,391 |
| Care | $82,352,114 |
| Testing | $42,846,030 |
| Governance and Systems | $39,782,360 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $116,340,262 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $63,870,684 |
| HVCT: Testing: HIV Testing and Counseling | $42,846,030 |
| HBHC: Care: Adult Care and Support | $36,896,409 |
| HVSI: Strategic Information | $25,700,005 |
| HVTB: Care: TB/HIV | $18,143,629 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $17,527,977 |
| PDTX: Treatment: Pediatric Treatment | $16,609,323 |
| HKID: Care: Orphans and Vulnerable Children | $14,838,304 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,898,438 |
| PDCS: Care: Pediatric Care and Support | $12,473,772 |
| OHSS: Health Systems Strengthening | $9,391,023 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,513,809 |
| HLAB: Laboratory Infrastructure | $4,691,332 |
| HTXD: Treatment: ARV Drugs | $3,079,936 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,422,483 |
| HMIN: Biomedical Prevention: Injection Safety | $150,000 |